Cofactors in human papillomavirus infection and cervical carcinogenesis

Archives of Gynecology and Obstetrics

Volumn 285, Issue 3, 2012, Pages 805-810

  Yetimalar, Hakan ^a   Kasap, Burcu ^a   Cukurova, Kulal ^a   Yildiz, Askin ^a   Keklik, Adnan ^a   Soylu, Ferit ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Carcinogenesis; Cervical cancer; Cervix neoplasm; Cofactors; HPV; HPV DNA; Human papillomavirus; Risk factors

Indexed keywords

PROGESTERONE; VIRUS DNA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CONDYLOMA ACUMINATUM; CONTRACEPTION; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; DNA HYBRIDIZATION; FEMALE; GENOTYPE; HORMONAL THERAPY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 82; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PARITY; POLYMERASE CHAIN REACTION; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; SMOKING HABIT; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS; CARCINOMA; CELL TRANSFORMATION; METABOLISM; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PREVALENCE; SEXUALITY; SMOKING; STATISTICS; UTERINE CERVIX DISEASE; UTERINE CERVIX TUMOR; VERRUCA VULGARIS; VIROLOGY;

ADOLESCENT; ADULT; AGED; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CONTRACEPTION; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PARITY; PREVALENCE; RISK FACTORS; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; SMOKING; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; WARTS; YOUNG ADULT;

EID: 84863223639     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2034-3     Document Type: Article

References (33)

1. Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walboomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, Meijer CL (2001) High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 10:101-106.
2. Winer RL, Lee SK, Hughes JP, Kiviat NB, Koutsky LA (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157:218-226.
3. Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, SchiVman M (2002) A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 94:1406-1414.
4. Lundberg GD (1989) The 1988 Bethesda system for reporting cervical/vaginal cytological diagnosis. JAMA 262:931-934.
5. Coutlee F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E (2002) Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902-907.
6. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identi-Wcation of human papillomavirus genotypes. J Clin Microbiol 40:779-787.
7. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) ClassiWcation of papillomaviruses. Virology 324:17-27.
8. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
9. Munoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classiWcation of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
10. Munoz N, Bosch FX, Castellsagué X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278-285.
11. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
12. Brinton LA, Tashima KT, Lehman HF, Levine RS, Mallin K, Savitz DA, Stolley PD, Fraumeni JF (1987) Epidemiology of cervical cancer by cell type. Cancer Res 47:1706-1711.
13. Ngelangel C, Munoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs MV, Santamaria M, Meijer CJ, Walboomers JM (1998) Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 90:43-49.
14. Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJ, Walboomers JM (1998) Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 90:50-57.
15. Lacey JVJ, Frisch M, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Hildesheim A (2001) Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 12:153-161.
16. Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J (2000) Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 83:1565-1572.
17. Altekruse SF, Lacey JVJ, Brinton LA, Gravitt PE, Silverberg SG, Barnes WAJ, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Hildesheim A (2003) Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol 188:657-663.
18. Munoz N, Franceschi S, Bosetti C, Moreno V, Smith JS, Shah KV, Meijer CJ, Bosch F (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359:1093-1101.
19. Parazzini F, La Vecchia C, Negri E, Fasoli M, Cecchetti G (1988) Risk factors for adenocarcinoma of the cervix: a case-control study. Br J Cancer 57:201-204.
20. Brinton LA, Herrero R, Reeves WC, de Britton RC, Gaitan E, Tenorio F (1993) Risk factors for cervical cancer by histology. Gynecol Oncol 51:301-306.
21. Hildesheim A, Herrero R, Castle P, Wacholder S, Bratti M, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, SchiVman M (2001) HPV cofactors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84:1219-1226.
22. Kvale G, Heuch I, Nilssen S (1988) Reproductive factors and risk of cervical cancer by cell type. A prospective study. Br J Cancer 58:820-824.
23. Bjorge T, Kravdal O (1996) Reproductive variables and risk of uterine cervical cancer in Norwegian registry data. Cancer Causes Control 7:351-357.
24. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S (2002) EVect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 359:1085-1092.
25. Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V (2003) Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361:1159-1167.
26. La Vecchia C, Altieri A, Franceschi S, Tavani A (2001) Oral contraceptives and cancer: an update. Drug Saf 24:741-754.
27. Manhart LE, Koutsky LA (2002) Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 29:725-735.
28. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ (1996) Human papillomavirus- the most signiWcant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 65:601-606.
29. Coker AL, Sanders LC, Bond SM, Gerasimova T, Pirisi L (2001) Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development. J Womens Health Gend Based Med 10:441-449.
30. Thomas DB, Ray RM (1995) Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO collaborative study of neoplasia and steroid contraceptives. Contraception 52:307-312.
31. Schmauz R, Okong P, de Villiers EM et al (1989) Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 43:805-809.
32. Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R (2002) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94:1604-1613.
33. Gravitt PE, Castle PE (2001) Chlamydia trachomatis and cervical squamous cell carcinoma. JAMA 285:1703-1704